---
schema_version: "secwatch.filing_event.v1"
accession: "0001356576-25-000046"
form_type: "8-K"
ticker: "SUPN"
cik: "0001356576"
company_name: "SUPERNUS PHARMACEUTICALS, INC."
filed_at: "2025-07-22T23:59:59+00:00"
generated_at: "2026-05-18T04:12:20.504666+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Supernus announces Q2 2025 earnings release and conference call on Aug 5, 2025

## Summary
- Press release states Q2 2025 results will be reported after market close on August 5, 2025.
- Conference call with President/CEO Jack Khattar and CFO Tim Dec on August 5 at 4:30 p.m. ET.
- No preliminary financial results or guidance are provided in this announcement.

## SEC filing metadata
- accession: 0001356576-25-000046
- form_type: 8-K
- ticker: SUPN
- cik: 0001356576
- company_name: SUPERNUS PHARMACEUTICALS, INC.
- filed_at: 2025-07-22T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1356576/000135657625000046/0001356576-25-000046-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1356576/000135657625000046/supn-20250722.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001356576-25-000046
- JSON: https://secwatch.observer/filing/0001356576-25-000046.json
- Plain text: https://secwatch.observer/filing/0001356576-25-000046.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.